Portage Biotech Stock (NASDAQ: PRTG) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 371.000 / 97.129K |
Day Range | - - - |
52 Wk Range | 0.200 - 4.400 |
Market Cap | $4.800M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 0.05% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Portage Biotech (NASDAQ: PRTG) through any online brokerage.
Other companies in Portage Biotech’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), NexImmune (NASDAQ:NEXI) and Genprex (NASDAQ:GNPX).
The latest price target for Portage Biotech (NASDAQ: PRTG) was reported by HC Wainwright & Co. on Monday, January 8, 2024. The analyst firm set a price target for 0.00 expecting PRTG to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Portage Biotech (NASDAQ: PRTG) is $0.2426 last updated Today at April 25, 2024 at 7:11 AM EDT.
There are no upcoming dividends for Portage Biotech.
Portage Biotech’s Q3 earnings are confirmed for Wednesday, February 28, 2024.
There is no upcoming split for Portage Biotech.
Portage Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.